Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Maha Katabi currently holds 12,500 shares of Vera Therapeutics, Inc. (VERA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Maha Katabi has been a net seller of VERA stock. They have purchased $30.5M and sold $34.1M worth of shares.
Maha Katabi's most recent insider trade was on Jun 5, 2024, when they sold 12,500 shares at $0.00 per share.
Maha Katabi serves as Executive at Vera Therapeutics, Inc. (VERA). They have executed 22 insider transactions totaling $64.6M over their tenure at the company.
Maha Katabi holds the position of Executive at Vera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Maha Katabi has shown a selling trading pattern, with $30.5M in total purchases and $34.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Maha Katabi was on Feb 26, 2024, when they sold $75.6M worth of RYZB shares. This transaction involved 1,209,764 shares at $62.50 per share.
Maha Katabi currently owns 12,500 shares of Vera Therapeutics, Inc. (VERA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Maha Katabi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Maha Katabi has 22 Form 4 filings on record as an insider at Vera Therapeutics, Inc..
Set alerts for Maha Katabi and 40,000+ other insiders.